Cargando…
miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer
BACKGROUND: Lung cancer is a common malignant tumor, with, non-small cell lung cancer (NSCLC) accounting for about 80–85% of cases. This study investigated the expression of miR-137 in NSCLC tissues and cells and its effects on the migration and invasion of NSCLC cells and related mechanisms. METHOD...
Autores principales: | Luo, Yutu, Hu, Suwei, Wang, Fang, Yang, Junjun, Gong, Daohui, Xu, Wenjing, Xu, Xingxiang, Min, Lingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641119/ https://www.ncbi.nlm.nih.gov/pubmed/36388045 http://dx.doi.org/10.21037/tcr-22-2177 |
Ejemplares similares
-
Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer
por: Min, Lingfeng, et al.
Publicado: (2018) -
AMPK α1 Downregulates ROS Levels Through Regulating Trx Leading to Dysfunction of Apoptosis in Non-Small Cell Lung Cancer
por: Gong, Daohui, et al.
Publicado: (2020) -
The demographic and treatment options for patients with large cell neuroendocrine carcinoma of the lung
por: Gu, Jianjun, et al.
Publicado: (2019) -
miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation
por: Zhang, Wei, et al.
Publicado: (2018) -
Long Noncoding RNA XIST Regulates miR-137–EZH2 Axis to Promote Tumor Metastasis in Colorectal Cancer
por: Liu, Xingxiang, et al.
Publicado: (2018)